APA (7th ed.) Citation

R, R., D, P., A, R., M, A., C, A., M, K., . . . A, M. (2024). REGENERATE-COBRA: A phase II randomized sham-controlled trial assessing the safety and efficacy of intracoronary administration of autologous bone marrow-derived cells in patients with refractory angina. American heart journal, 275, 96. https://doi.org/10.1016/j.ahj.2024.06.001

Chicago Style (17th ed.) Citation

R, Ramaseshan, Perera D, Reid A, Andiapen M, Ariti C, Kelham M, Jones DA, and Mathur A. "REGENERATE-COBRA: A Phase II Randomized Sham-controlled Trial Assessing the Safety and Efficacy of Intracoronary Administration of Autologous Bone Marrow-derived Cells in Patients with Refractory Angina." American Heart Journal 275 (2024): 96. https://doi.org/10.1016/j.ahj.2024.06.001.

MLA (9th ed.) Citation

R, Ramaseshan, et al. "REGENERATE-COBRA: A Phase II Randomized Sham-controlled Trial Assessing the Safety and Efficacy of Intracoronary Administration of Autologous Bone Marrow-derived Cells in Patients with Refractory Angina." American Heart Journal, vol. 275, 2024, p. 96, https://doi.org/10.1016/j.ahj.2024.06.001.